Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (3)
  • Penn Non-Treatment Trials (6)
  • Phase 1: Solid Tumor Trials (3)
  • Proton Therapy Trials (2)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
UPCC 03909 Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer II Signal Transduction Inhibitor PD 0332991
CA186-011 A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of BMS-663513 (Anti-CD137) in Subjects With Advanced and/or Metastatic Solid Tumors I Immunotherapy BMS-663513
UPCC 09211 A Feasibility and Registration Study of Proton Radiotherapy for Upper Gastrointestinal Malignancies Not Specified Radiotherapy, Proton Therapy Not Applicable
Displaying: 1 - 3 of 3 Results
  • < Previous
  • 1
  • Next >